Revance Therapeutics, Inc.

Legal & General Group Plc

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/13/2025

Shares

110,199

Value ($000)

335

Weight

0.0%

2019 Q4 - 2024 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/13/2025	335	0.0%	110,199	12/31/2024
2024 Q3	2/28/2025	547	0.0%	105,473	9/30/2024
2024 Q2	5/29/2025	167	0.0%	65,044	6/30/2024
2024 Q1	5/29/2025	409	0.0%	83,172	3/31/2024
2023 Q4	5/29/2025	734	0.0%	83,463	12/31/2023
2023 Q3	11/14/2023	955	0.0%	83,300	9/30/2023
2023 Q2	8/14/2023	1,972	0.0%	77,918	6/30/2023
2023 Q1	5/15/2023	1,365	0.0%	42,377	3/31/2023
2022 Q4	2/14/2023	641	0.0%	34,742	12/31/2022
2022 Q3	11/14/2022	891	0.0%	33,025	9/30/2022
2022 Q2	8/22/2022	575	0.0%	41,619	6/30/2022
2022 Q1	5/16/2022	817	0.0%	41,900	3/31/2022
2021 Q4	2/14/2022	675	0.0%	41,362	12/31/2021
2021 Q3	11/15/2021	896	0.0%	32,175	9/30/2021
2021 Q2	8/12/2021	560	0.0%	18,879	6/30/2021
2021 Q1	5/17/2021	510	0.0%	18,254	3/31/2021
2020 Q4	2/12/2021	484	0.0%	17,090	12/31/2020
2020 Q3	11/13/2020	455	0.0%	18,094	9/30/2020
2020 Q2	8/14/2020	485	0.0%	19,871	6/30/2020
2020 Q1	5/14/2020	283	0.0%	19,064	3/31/2020
2019 Q4	2/13/2020	298	0.0%	18,326	12/31/2019